Synaps Dx is dedicated to transforming the diagnosis of Alzheimer’s disease (AD). Operating a CLIA-certified laboratory, we offer DISCERN™, the first commercially available test to accurately detect AD (>95%).
info@synapsdx.com
Granted Breakthrough Status by the FDA, DISCERN™ provides a convenient, accurate, minimally invasive diagnosis of Alzheimer’s disease. Through analysis of one (1) small in-office skin biopsy provided by a referring physician, SDx offers a reliable and accurate alternative to traditional diagnostic methods. Our diagnostic biomarkers have been confirmed by neuropathological validation (NIH “Gold Standard”).
Company Details
- Employees
- 21
- Founded
- -
- Address
- 12441 Parklawn Dr,
- Industry
- Biotechnology
- Website
- https://www.synapsdx.com/
- Keywords
- New York.
- HQ
- Rockville, MD
- Competitors
- The New York Academy of Medicine, Scalability - A brand, design, and technology agency based in New York., MicroSigX Biotech Diagnostic Limited, A Diagnostic Company, Alzheimer's Drug Discovery Foundation, Norton Neuroscience Institute, CastleRock Investors Fund LLC, AMERICAN BRAIN COALITION, BrainCheck, Avalo Therapeutics.
Synaps Dx - An Alzheimer's Diagnostic Company Questions
Synaps Dx - An Alzheimer'S Diagnostic Company's website is https://www.synapsdx.com/
Synaps Dx - An Alzheimer'S Diagnostic Company's LinkedIn profile is https://www.linkedin.com/company/synapsdx
Synaps Dx - An Alzheimer'S Diagnostic Company has
21 employees.
View email and phone details for 21
employees at Synaps Dx - An Alzheimer'S Diagnostic Company.
Synaps Dx - An Alzheimer'S Diagnostic Company's industry is
Biotechnology
Synaps Dx - An Alzheimer'S Diagnostic Company's top competitors are
The New York Academy Of Medicine,
Scalability - A Brand, Design, And Technology Agency Based In New York.,
Microsigx Biotech Diagnostic Limited,
A Diagnostic Company,
Alzheimer's Drug Discovery Foundation,
Norton Neuroscience Institute,
Castlerock Investors Fund Llc,
American Brain Coalition,
Braincheck,
Avalo Therapeutics.
Synaps Dx - An Alzheimer'S Diagnostic Company's categories are Biotechnology
Synaps Dx - An Alzheimer'S Diagnostic Company's founding year is 2016
